James A. Johnson, Director at Athira Pharma, Inc. (ATHA), bought 5,000 shares at $2.40 ($12K) on 2023-03-29, disclosed to the SEC on 2023-03-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ZGEN | SELL | 2009-12-08 | $70K | — | Filing → |
| ZGEN | SELL | 2009-09-02 | $60K | — | Filing → |
| ZGEN | SELL | 2006-08-25 | $60K | — | Filing → |